GENERIC PHARMACEUTICAL ASSOCIATION

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

180

Firms Hired

Active Period

1999–2018

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2018	—	1	1
2017	—	4	1
2016	—	3	2
2015	—	5	2
2014	—	10	2
2013	—	15	4
2012	—	9	2
2011	—	13	4
2010	—	20	6
2009	—	25	6
2008	—	22	5
2007	—	13	5
2006	—	5	3
2005	—	5	3
2004	—	7	3
2003	—	4	2
2002	—	7	3
2001	—	4	2
2000	—	3	1
1999	—	5	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
FIERCE, ISAKOWITZ & BLALOCK	—	41
JENNINGS POLICY STRATEGIES	—	26
GREENBERG TRAURIG LLP	—	17
THE RUSSELL GROUP, INC.	—	13
BOCKORNY GROUP, INC.	—	13
ALSTON & BIRD LLP	—	12
VAN HEUVELEN STRATEGIES, LLC	—	8
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ	—	11
MFJ INTERNATIONAL	—	32
LATHAM & WATKINS LLP	—	7

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	149
SENATE	149
Health & Human Services, Dept of (HHS)	34
Food & Drug Administration (FDA)	26
U.S. Trade Representative (USTR)	26
White House Office	21
Executive Office of the President (EOP)	11
Office of Management & Budget (OMB)	8
Centers For Medicare and Medicaid Services (CMS)	5
Congressional Budget Office (CBO)	5
Patent & Trademark Office (PTO)	5
Federal Trade Commission (FTC)	1
State, Dept of (DOS)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	98
Health Issues	Health Issues	89
Trade (domestic/foreign)	Trade (domestic/foreign)	57
Copyright/Patent/Trademark	Copyright/Patent/Trademark	55
Medicare/Medicaid	Medicare/Medicaid	52
Budget/Appropriations	Budget/Appropriations	18
Insurance	Insurance	16
Labor Issues/Antitrust/Workplace	Labor Issues/Antitrust/Workplace	5
Consumer Issues/Safety/Products	Consumer Issues/Safety/Products	4
Telecommunications	Telecommunications	2
Law Enforcement/Crime/Criminal Justice	Law Enforcement/Crime/Criminal Justice	2
Marine/Maritime/Boating/Fisheries	Marine/Maritime/Boating/Fisheries	2
Energy/Nuclear	Energy/Nuclear	2
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	1
Food Industry (safety, labeling, etc.)	Food Industry (safety, labeling, etc.)	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2841114th Congress

FAST Generics Act of 2015

2016 · first_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Drug Affordability and Access Issues 21st Century Cures Initiative and Related Legislative Proposals Advanced Medicines Initiative HR 2841, FAST Generics Act of 2015 (Fair Access for Safe and Timely Generics)

Client expense: — · Firm income: $20,000

Matched citations: HR 2841

H.R. 2841114th Congress

FAST Generics Act of 2015

2015 · fourth_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Drug Affordability and Access Issues 21st Century Cures Initiative and Related Legislative Proposals Advanced Medicines Initiative HR 2841, FAST Generics Act of 2015 (Fair Access for Safe and Timely Generics)

Client expense: — · Firm income: $50,000

Matched citations: HR 2841

H.R. 2841114th Congress

FAST Generics Act of 2015

2015 · third_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Drug Affordability and Access Issues 21st Century Cures Initiative and Related Legislative Proposals Advanced Medicines Initiative HR 2841, FAST Generics Act of 2015 (Fair Access for Safe and Timely Generics)

Client expense: — · Firm income: $50,000

Matched citations: HR 2841

H.R. 2841114th Congress

FAST Generics Act of 2015

2015 · second_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Drug Affordability and Access Issues 21st Century Cures Initiative and Related Legislative Proposals Advanced Medicines Initiative HR 2841, FAST Generics Act of 2015 (Fair Access for Safe and Timely Generics)

Client expense: — · Firm income: $50,000

Matched citations: HR 2841

Show 21 more cited filings

H.R. 2725113th Congress

Food and Drug Administration Safety Over Sequestration Act of 2013

2014 · second_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3204, Drug Quality and Security Act H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013 S. 1413, FDA User Fee Protection Act S. 504, Fair And Immediate Release of Generic Drugs Act

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2725

H.R. 3204113th Congress

Drug Quality and Security Act

2014 · second_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3204, Drug Quality and Security Act H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013 S. 1413, FDA User Fee Protection Act S. 504, Fair And Immediate Release of Generic Drugs Act

Client expense: — · Firm income: $50,000

Matched citations: H.R. 3204

S. 1413113th Congress

FDA User Fee Protection Act

2014 · second_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3204, Drug Quality and Security Act H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013 S. 1413, FDA User Fee Protection Act S. 504, Fair And Immediate Release of Generic Drugs Act

Client expense: — · Firm income: $50,000

Matched citations: S. 1413

S. 214113th Congress

Preserve Access to Affordable Generics Act

2014 · second_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues relating to Patent Settlements. S. 214, Preserve Access to Affordable Generics Act

Client expense: — · Firm income: $50,000

Matched citations: S. 214

S. 504113th Congress

FAIR Generics Act

2014 · second_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3204, Drug Quality and Security Act H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013 S. 1413, FDA User Fee Protection Act S. 504, Fair And Immediate Release of Generic Drugs Act

Client expense: — · Firm income: $50,000

Matched citations: S. 504

S. 959113th Congress

Pharmaceutical Quality, Security, and Accountability Act

2014 · second_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

S.959, Pharmaceutical Quality, Security, and Accountability Act Issues Related to Biosimilar Regulation, Labeling, E-Labeling and Access Issues Related to the newly-formed Affordable Medicine Caucus

Client expense: — · Firm income: $50,000

Matched citations: S.959

H.R. 2725113th Congress

Food and Drug Administration Safety Over Sequestration Act of 2013

2014 · second_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3204, Drug Quality and Security Act H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013 S. 1413, FDA User Fee Protection Act S. 504, Fair And Immediate Release of Generic Drugs Act

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2725

H.R. 3204113th Congress

Drug Quality and Security Act

2014 · second_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3204, Drug Quality and Security Act H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013 S. 1413, FDA User Fee Protection Act S. 504, Fair And Immediate Release of Generic Drugs Act

Client expense: — · Firm income: $50,000

Matched citations: H.R. 3204

S. 1413113th Congress

FDA User Fee Protection Act

2014 · second_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3204, Drug Quality and Security Act H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013 S. 1413, FDA User Fee Protection Act S. 504, Fair And Immediate Release of Generic Drugs Act

Client expense: — · Firm income: $50,000

Matched citations: S. 1413

S. 214113th Congress

Preserve Access to Affordable Generics Act

2014 · second_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues relating to Patent Settlements. S. 214, Preserve Access to Affordable Generics Act

Client expense: — · Firm income: $50,000

Matched citations: S. 214

S. 504113th Congress

FAIR Generics Act

2014 · second_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3204, Drug Quality and Security Act H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013 S. 1413, FDA User Fee Protection Act S. 504, Fair And Immediate Release of Generic Drugs Act

Client expense: — · Firm income: $50,000

Matched citations: S. 504

S. 959113th Congress

Pharmaceutical Quality, Security, and Accountability Act

2014 · second_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

S.959, Pharmaceutical Quality, Security, and Accountability Act Issues Related to Biosimilar Regulation, Labeling, E-Labeling and Access Issues Related to the newly-formed Affordable Medicine Caucus

Client expense: — · Firm income: $50,000

Matched citations: S.959

H.R. 2725113th Congress

Food and Drug Administration Safety Over Sequestration Act of 2013

2014 · first_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3204, Drug Quality and Security Act H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013 S. 1413, FDA User Fee Protection Act S. 504, Fair And Immediate Release of Generic Drugs Act

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2725

H.R. 3204113th Congress

Drug Quality and Security Act

2014 · first_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.3204, Drug Quality and Security Act S.957, Drug Supply Chain Security Act S.959, Pharmaceutical Quality, Security, and Accountability Act Issues Related to Biosimilar Regulation, Labeling, E-Labeling and Access

Client expense: — · Firm income: $50,000

Matched citations: H.R.3204

H.R. 3204113th Congress

Drug Quality and Security Act

2014 · first_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3204, Drug Quality and Security Act H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013 S. 1413, FDA User Fee Protection Act S. 504, Fair And Immediate Release of Generic Drugs Act

Client expense: — · Firm income: $50,000

Matched citations: H.R. 3204

S. 1413113th Congress

FDA User Fee Protection Act

2014 · first_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3204, Drug Quality and Security Act H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013 S. 1413, FDA User Fee Protection Act S. 504, Fair And Immediate Release of Generic Drugs Act

Client expense: — · Firm income: $50,000

Matched citations: S. 1413

S. 214113th Congress

Preserve Access to Affordable Generics Act

2014 · first_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues relating to Patent Settlements. S. 214, Preserve Access to Affordable Generics Act

Client expense: — · Firm income: $50,000

Matched citations: S. 214

S. 504113th Congress

FAIR Generics Act

2014 · first_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3204, Drug Quality and Security Act H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013 S. 1413, FDA User Fee Protection Act S. 504, Fair And Immediate Release of Generic Drugs Act

Client expense: — · Firm income: $50,000

Matched citations: S. 504

S. 957113th Congress

Drug Supply Chain Security Act

2014 · first_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.3204, Drug Quality and Security Act S.957, Drug Supply Chain Security Act S.959, Pharmaceutical Quality, Security, and Accountability Act Issues Related to Biosimilar Regulation, Labeling, E-Labeling and Access

Client expense: — · Firm income: $50,000

Matched citations: S.957

S. 959113th Congress

Pharmaceutical Quality, Security, and Accountability Act

2014 · first_quarter · Firm: BOCKORNY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.3204, Drug Quality and Security Act S.957, Drug Supply Chain Security Act S.959, Pharmaceutical Quality, Security, and Accountability Act Issues Related to Biosimilar Regulation, Labeling, E-Labeling and Access

Client expense: — · Firm income: $50,000

Matched citations: S.959

H.R. 2725113th Congress

Food and Drug Administration Safety Over Sequestration Act of 2013

2013 · fourth_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3204, Drug Quality and Security Act H.R. 2725, S. 1413, FDA User fee sequestration issues

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2725

Source: Senate LDA

GENERIC PHARMACEUTICAL ASSOCIATION — Lobbying Disclosure | Poliscope